Centre clears Mumbai's Haffkine institute to make Covaxin

Gallery

MORE...

Sports

Hockey India names Amir Ali-led 20-man team for Junior Asia Cup

Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual

Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award

World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17

U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals

FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup

Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow

MORE...

Centre clears Mumbai's Haffkine institute to make Covaxin

Last Updated : 16 Apr 2021 10:40:48 AM IST

Covaxin

In a major step to ramp up vaccine production amid the Covid-19 second wave, the Centre has approved production of Corona vaccines from the Maharashtra government-owned Haffkine Institute in Mumbai.

Since the past month, Chief Minister Uddhav Thackeray had repeatedly requested Prime Minister Narendra Modi to allow production of vaccines in the renowned institution in central Mumbai.

The central approval came late on Thursday night green-flagging the 122-year-old Haffkine Institute, Parel, to produce the Bharat Biotech's Covaxin for one-year under a technology transfer agreement.

Shortly after the announcement, Thackeray thanked the PM for the formal nod, sent by the Department of Science & Technology Secretary to state Chief Secretary Sitaram Kunte of the approval for a period of 12 months.

The Haffkine Institute has the capacity to produce 22-crore doses annually, which would immensely help the ongoing Vaccination drive in the country with complaints of vaccine shortages coming up from several states including Maharashtra.